Baldwin Wealth Partners’s AXS Cannabis ETF THCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16
Closed -$270 743
2023
Q4
$270 Hold
16
﹤0.01% 711
2023
Q3
$296 Hold
16
﹤0.01% 737
2023
Q2
$274 Hold
16
﹤0.01% 753
2023
Q1
$344 Buy
+16
New +$401 ﹤0.01% 784
2022
Q4
Sell
-175
Closed -$5K 837
2022
Q3
$5K Hold
175
﹤0.01% 570
2022
Q2
$6K Hold
175
﹤0.01% 584
2022
Q1
$13K Hold
175
﹤0.01% 520
2021
Q4
$15K Hold
175
﹤0.01% 476
2021
Q3
$22K Hold
175
﹤0.01% 449
2021
Q2
$30K Hold
175
﹤0.01% 422
2021
Q1
$34K Buy
+175
New +$34.3K ﹤0.01% 388

Baldwin Wealth Partners's THCX Position: Q1 2024 in Review

Baldwin Wealth Partners sold out of AXS Cannabis ETF (THCX) in Q1 2024, closing a stake of 16 shares — an estimated $270 sold.

Baldwin Wealth Partners first reported a position in THCX in Q1 2021 and held it in 11 quarters. The position peaked at $34K in Q1 2021. 0 funds tracked by Wall St. Rank hold THCX as of Q1 2024.

  • Baldwin Wealth Partners reported no remaining AXS Cannabis ETF position as of Q1 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 16 AXS Cannabis ETF shares in Q1 2024, an estimated $270.
  • Baldwin Wealth Partners first reported a position in AXS Cannabis ETF in Q1 2021 and held it in 11 quarters.
  • Baldwin Wealth Partners's AXS Cannabis ETF position peaked at $34K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q1 2024.

Based on Baldwin Wealth Partners's 13F filing for Q1 2024, filed 12 Apr 2024.